OPA Investments, Inc. – Trademark Portfolio

Entity Type: 03

OPA Investments, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HELIODYNE. The owner is based in Panama.

Panama , PA

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HELIODYNE
HELIODYNE
Registered 2007
OPA
OPA
Abandoned 2001

Trademark Classifications

OPA Investments, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does OPA Investments, Inc. have?

OPA Investments, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does OPA Investments, Inc. file in?

OPA Investments, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 10 (Medical Apparatus). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.

What are OPA Investments, Inc.'s most well-known trademarks?

OPA Investments, Inc.'s registered trademark portfolio includes well-known marks such as HELIODYNE. These are among 1 currently registered trademark in the portfolio.

What is OPA Investments, Inc.'s trademark registration success rate?

OPA Investments, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.